Serial Number | 97377210 |
Word Mark | LISATA |
Filing Date | Friday, April 22, 2022 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Friday, November 10, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 18, 2023 |
Goods and Services | Pharmaceutical preparations for use in cancer, tumors, diabetic kidney disease, coronary microvascular dysfunction, Buerger's Disease, and Critical Limb Ischemia; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology, cardiology, vascular system, and ischemia; Therapeutic pharmaceutical preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for promoting ischematic repair, regenerating damaged tissue, stimulating the repair or growth of microvasculature, penetrating tissue surrounding tumors, and altering immunosuppressive tumor microenvironments |
Translation of Words in Mark | The English translation of "LISATA" in the mark is "AUGMENT". |
Goods and Services | Research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Drug discovery services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, April 28, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, April 28, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | LISATA THERAPEUTICS, INC. |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 03 - Corporation |
Address | BASKING RIDGE, NJ 07920 |
Party Name | Caladrius Biosciences, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Basking Ridge, NJ 07920 |
Party Name | Caladrius Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Basking Ridge, NJ 07920 |
Event Date | Event Description |
Wednesday, November 22, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, November 14, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, November 10, 2023 | SOU EXTENSION 1 GRANTED |
Friday, November 10, 2023 | SOU EXTENSION 1 FILED |
Friday, November 10, 2023 | SOU TEAS EXTENSION RECEIVED |
Tuesday, June 13, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, April 18, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 18, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, March 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, March 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, March 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, February 16, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, February 16, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, February 16, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, February 9, 2023 | ASSIGNED TO EXAMINER |
Thursday, April 28, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, April 26, 2022 | NEW APPLICATION ENTERED |